iconEarnings Announcement Before Market Open

Royalty Pharma PLC RPRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/08/24 EDT
27.99quote price arrow down-0.29 (-1.03%)
Volume
3,145,547
52 week range
25.92 - 35.52
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close27.99
  • 52 Week High35.52
  • 52 Week High Date05/09/23
  • 52 Week Low25.92
  • 52 Week Low Date09/21/23

Key Stats

  • Market Cap16.722B
  • Shares Out597.44M
  • 10 Day Average Volume2.93M
  • Dividend0.84
  • Dividend Yield3.00%
  • Beta0.48
  • YTD % Change-0.36

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close27.99
  • 52 Week High35.52
  • 52 Week High Date05/09/23
  • 52 Week Low25.92
  • 52 Week Low Date09/21/23
  • Market Cap16.722B
  • Shares Out597.44M
  • 10 Day Average Volume2.93M
  • Dividend0.84
  • Dividend Yield3.00%
  • Beta0.48
  • YTD % Change-0.36

RATIOS/PROFITABILITY

  • EPS (TTM)2.53
  • P/E (TTM)11.05
  • Fwd P/E (NTM)7.08
  • EBITDA (TTM)1.492B
  • ROE (TTM)18.67%
  • Revenue (TTM)2.355B
  • Gross Margin (TTM)-
  • Net Margin (TTM)72.20%
  • Debt To Equity (MRQ)94.01%

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date05/16/2024
  • Div Amount0.21
  • Split Date-
  • Split Factor-

Latest On Royalty Pharma PLC

 

Profile

MORE
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya...
Pablo Legorreta
Chairman of the Board, Chief Executive Officer
Christopher Hite
Vice Chairman, Executive Vice President
Terrance Coyne
Chief Financial Officer, Executive Vice President
George Lloyd
Executive Vice President - Investments and Chief Legal Officer
Marshall Urist M.D., Ph.D.
Executive Vice President - Research and Investments
Address
110 East 59th Street
New York, NY
10022
United States

Top Peers

SYMBOLLASTCHG%CHG
UTHR
United Therapeutics Corp
261.09-5.13-1.93%
BMRN
Biomarin Pharmaceutical Inc
81.83-0.75-0.91%
CTLT
Catalent Inc
56.20-0.33-0.58%
IONS
Ionis Pharmaceuticals Inc
40.16-0.77-1.88%
BPMC
Blueprint Medicines Corp
108.78+0.23+0.21%